The Key Role of Nucleic Acid Vaccines for One Health
- PMID: 33567520
- PMCID: PMC7916035
- DOI: 10.3390/v13020258
The Key Role of Nucleic Acid Vaccines for One Health
Abstract
The ongoing SARS-CoV-2 pandemic has highlighted both the importance of One Health, i.e., the interactions and transmission of pathogens between animals and humans, and the potential power of gene-based vaccines, specifically nucleic acid vaccines. This review will highlight key aspects of the development of plasmid DNA Nucleic Acid (NA) vaccines, which have been licensed for several veterinary uses, and tested for a number of human diseases, and will explain how an understanding of their immunological and real-world attributes are important for their efficacy, and how they helped pave the way for mRNA vaccines. The review highlights how combining efforts for vaccine development for both animals and humans is crucial for advancing new technologies and for combatting emerging diseases.
Keywords: Cytolytic T Lymphocyte (CTL); DNA vaccines; immune responses; mRNA vaccines; one health; plasmid.
Conflict of interest statement
MAL owns Merck shares as part of her retirement; Merck is on record as developing mRNA for cancer therapy. AF declares no conflict of interest. The authors alone are responsible for the views expressed in this article and they do not necessarily represent the views, decisions or policies of the institutions with which they are affiliated.
References
-
- Fu T.-M., Ulmer J.B., Caulfield M.J., Deck R.R., Friedman A., Wang S., Liu X., Donnelly J.J., Liu M.A., Wigzell H. Priming of Cytotoxic T Lymphocytes by DNA Vaccines: Requirement for Professional Antigen Presenting Cells and Evidence for Antigen Transfer from Myocytes. Mol. Med. 1997;3:362–371. doi: 10.1007/BF03401683. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous
